Podcasts about breyer capital

Menopause brings to the table a variety of physiological symptoms, including gut health issues. Women in perimenopause start to experience increased constipation, diarrhea, gas, and bloating. Other signs that a woman's gut health may be in dysbiosis are hair loss, skin changes like acne, joint pain, newly diagnosed autoimmune conditions, and weight gain. How many of you have tried different medications, diets, and supplements to heal your gut? It's not normal to experience these gut health issues. It's time to address your gut health so that you can focus on your fitness, sleep, nutrition, and optimal health outcomes as you transition through menopause and continue to enjoy your post-menopausal years. You will be post-menopausal for the next 20, 30, and 40 years of life, hopefully. How do you want to feel, live, and exist in your 70s, 80s, and 90s? Gut health plays a dominant role in your overall well-being. In this episode, learn how AI will play a role in assessing your gut microbiome's health through stool testing and the thousands of published papers on the gut microbiome. JONA's technology uses AI to drive a customer's personalized gut health protocol through lifestyle interventions, possible supplementation, and strains of microbes that may be beneficial to you. They have not developed a supplement line to use and have no intention to do so, which is something very unique to them. Their testing may take the guessing out and support you with personalized actionable steps to take to support better gut health and health outcomes.My guest today is Leo Grady, the founder and CEO of JONA, an AI-driven gut microbiome company. Leo is internationally recognized for his work to deliver AI in healthcare for 20 years at pioneering Bay Area startups (HeartFlow), multinational medical companies (Siemens), and, most recently, as CEO of Paige.ai. As CEO of Paige, Leo led the company to become an industry leader, internationally launching groundbreaking products and receiving the first-ever FDA approval for an AI product in pathology. Leo is currently CEO in Residence with Breyer Capital and Founder and CEO with Jona.Medical Disclaimer:By listening to this podcast, you agree not to use this podcast as medical advice or to make any lifestyle changes to treat any medical condition in yourself or others. Consult your own physician for any medical issues that you may be having. This entire disclaimer also applies to any of my guests on my podcast.To learn more about JONA:Website: https://jona.health/IG: @jonahealthFB: https://www.facebook.com/JonaHealth/Order a test and save $50: https://jona.health/products/microbiome-testStay connected to JFW:Watch on my YouTube channel: https://www.youtube.com/@jillfooswellness/videosFollow me on Instagram: https://www.instagram.com/jillfooswellness/Follow me on Facebook: https://www.facebook.com/jillfooswellnessGrab discounts on my favorite biohacking products: https://www.jillfooswellness.com/health-productsEnjoy 20% savings and free shipping at Fullscript for your favorite supplements by leading brands:https://us.fullscript.com/welcome/jillfooswellnessSubscribe to the JFW newsletter at www.jillfooswellness.com and receive your FREE Guide on How To Increase Your Protein in 5 Easy Steps and your free Protein Powder Recipe Ebook. Schedule your complimentary 30-minute Zoom consultation here:https://calendly.com/jillfooswellness/30-minute-zoom-consultations

Episode 100 of the One Thing Podcast with Dr. Adam Rinde did not disappoint First, some goodies to mention. To order the Jona test we talk about this episode... go to https://jona.health and enter ONETHING100 to receive $100 off the test In this episode I welcome on the CEO of Jona, Leo Grady, PhD and the Director of Business Development and GTM strategy , Jaclyn Kawwas. We are discussing a revolutionary stool microbiome test called Jona that uses AI to analyze gut microbiome data and connect it to health outcomes: Jona, developed an AI system to analyze microbiome data obtained through shotgun metagenomic sequencing. The AI system is able to: 1. Read and interpret existing research on the microbiome 2. Match patterns in an individual's microbiome data to relevant studies. 3. Generate personalized recommendations for dietary changes, lifestyle modifications, and supplements based on an individual's health goals The gut microbiome is highly individualized and influenced by various factors: We highlight how the gut microbiome is highly personalized, with limited overlap between individuals. Factors contributing to microbiome variability include: Diet: Processed foods, artificial sweeteners, emulsifiers, preservatives, fiber intake Lifestyle: Exercise, travel, pet ownership Medications: Antibiotics, chemotherapy, opioids Infections: Salmonella poisoning, C. difficile infection, long COVID, PANDAS/PANS Some highlights to our discussion: We discuss hwo stool testing technology has evolved We discuss metabolomics and how it provides additional insight into gut health: We discuss how the field of microbiome research is rapidly evolving: We discuss personalized recommendations that Jona makes. About our guests: Leo Grady, PhD Leo is internationally recognized for his work to deliver AI in healthcare for 20 years at pioneering bay area startups (HeartFlow), multinational medical companies (Siemens) and, most recently, as CEO of Paige.ai. As CEO of Paige, Leo led the company to become an industry leader, internationally launching groundbreaking products and receiving the first-ever FDA approval for an AI product in pathology. Leo authored two books on AI, over 100 peer-reviewed scientific papers and is an inventor on over 300 patents. Winner of the Edison Patent Award, he was inducted as Fellow in the American Institute for Medical and Biological Engineering. Leo earned a Ph.D. in Cognitive and Neural Systems from BU. Leo is CEO in Residence with Breyer Capital and the Founder and CEO of Jona. Jaclyn Kawwas, MBA Jaclyn has dedicated her career to advancing medical and health technology, striving to combat the growing challenges of chronic illness. During her tenure at Medtronic, she contributed to the design and development of cutting-edge cardiovascular devices, including one that garnered FDA approval for hypertension treatment. Her solutions have earned her multiple patents in cardiovascular disease management. Currently serving as the Head of Business Development and GTM Strategy at Jona, a health tech AI company specializing in the gut microbiome, Jaclyn continues to sit at the intersection of technology and healthcare. Prior to her role at Jona, she held positions in business development and growth strategy at Viz.ai and Thirty Madison which focus on chronic conditions from both a provider and consumer lens. Jaclyn received her B.S.E. in biomedical engineering from the University of Michigan and an MBA in Healthcare Management from The Wharton School at the University of Pennsylvania. She remains committed to leveraging technology to make a positive impact on preventive health and patient care. Show notes available at : https://onethingpod/jona --- Send in a voice message: https://podcasters.spotify.com/pod/show/onethingpod/message Support this podcast: https://podcasters.spotify.com/pod/show/onethingpod/support

Welcome to the latest edition of the Mind Gut Conversation Podcast, a place to learn about the latest ideas from thought leaders in the area of optimal health, the science of mind gut microbiome interactions, food and the environment. Today I have the great pleasure to speak to Leo Grady, AI expert and CEO of the microbiome company Jona. Leo earned a Ph.D. in Cognitive and Neural Systems from BU and is the Founder and CEO of Jona and CEO in Residence with Breyer Capital. Leo is internationally recognized for his work to deliver AI in healthcare for 20 years at pioneering bay area startups, multinational medical companies, including Siemens and, most recently, as CEO of Paige.ai. As CEO of Paige, he led the company to become an industry leader, internationally launching groundbreaking products and receiving the first-ever FDA approval for an AI product in pathology. Leo authored two books on AI, over 100 peer-reviewed scientific papers and is an inventor on over 300 patents. Winner of the Edison Patent Award, he was inducted as Fellow in the American Institute for Medical and Biological Engineering. As Founder and CEO of Jona, he has developed a stool microbiome analysis platform which not only uses state of the art analysis approaches to study the structure and function of from individual stool samples, but also provides users with an AI assisted interpretation of the results. Follow Dr. Mayer: https://linktr.ee/emayer

Welcome to the latest edition of the Mind Gut Conversation Podcast, a place to learn about the latest ideas from thought leaders in the area of optimal health, the science of mind gut microbiome interactions, food and the environment. Today I have the great pleasure to speak to Leo Grady, AI expert and CEO of the microbiome company Jona. Leo earned a Ph.D. in Cognitive and Neural Systems from BU and is the Founder and CEO of Jona and CEO in Residence with Breyer Capital. Leo is internationally recognized for his work to deliver AI in healthcare for 20 years at pioneering bay area startups, multinational medical companies, including Siemens and, most recently, as CEO of Paige.ai. As CEO of Paige, he led the company to become an industry leader, internationally launching groundbreaking products and receiving the first-ever FDA approval for an AI product in pathology. Leo authored two books on AI, over 100 peer-reviewed scientific papers and is an inventor on over 300 patents. Winner of the Edison Patent Award, he was inducted as Fellow in the American Institute for Medical and Biological Engineering. As Founder and CEO of Jona, he has developed a stool microbiome analysis platform which not only uses state of the art analysis approaches to study the structure and function of from individual stool samples, but also provides users with an AI assisted interpretation of the results. Follow Dr. Mayer: https://linktr.ee/emayer

Sam Corcos is the Co-Founder & CEO @ Levels, the company helping you see how food affects your health with data from biosensors like continuous glucose monitors (CGMs). To date, Sam has raised over $89M for Levels from the likes of a16z (Jeff Jordan sits on his board), Founder Collective, Breyer Capital and Shrug Capital to name a few. Prior to Levels, Sam founded two prior companies, CarDash; a Y Combinator company that makes automotive repair and maintenance convenient. Before Cardash, Sam founded, Sightline Maps, an intuitive platform for 3D printing and visualizing topographical maps, marketed primarily towards the U.S. military. In Today's Episode with Sam Corcos: 1. The Founding Moment: What was the a-ha moment for Sam with the founding Levels? What were the big mistakes Sam made with prior companies that he did not take with him to Levels? What does Sam know now that he wishes he had known when he started Levels? 2. How to Fundraise Like a Pro: Why does Sam believe that founders should take as many meetings with VCs as possible? What are the biggest mistakes founders make when meeting investors? Should founders meet with associates in the fundraising process? What does Sam mean when he says, "you have to create theater" when pitching? 3. How to Extract the Most Value from Your Investors: What have been Sam's biggest lessons on how to put your investors to work? What is the right and most strategic way to ask investors for specific help? How can founders create a competitive environment where VCs are competing to help? Which investors have been the most helpful? Why are post-IPO operators the best angels to have as investors? How has the a16z platform team been such a needle mover? 4. How to Find Your Partner and Master Parenting: What does Sam mean when he says he had a "one pager" in what he wanted in a partner? What was in the one-pager? How did dates respond? What are the biggest mistakes people make when dating? What is Sam most nervous about on becoming a parent? How does Sam think having a child will impact his marriage?

Produced by Foundersuite (www.foundersuite.com), "How I Raised It" goes behind the scenes with startup founders and investors who have raised capital. This episode is with Ben Lamm of Colossal Biosciences, a startup using genetics to bring back extinct animals such as the wooly mammoth, Tasmanian tiger, and the Dodo bird. Learn more at https://colossal.com/ In this episode we talk about the technology and the "why" behind de-extinction science, raising capital for a moonshot, how to identify investors with a long event horizon and much more. Colossal Biosciences has raised over $225 million in total. The Company's most recent round was a $150 million Series B led by US Innovative Technology Fund with participation from Breyer Capital, WestRiver Group, Animal Capital, In-Q-Tel, Animoca Brands, Peak 6, Bold Capital, Jazz Venture Partners and others. Previous investors include Thomas Tull and At One Ventures. How I Raised It is produced by Foundersuite, makers of software to raise capital and manage investor relations. Foundersuite's customers have raised over $9.7 Billion since 2016. Create a free account at www.foundersuite.com.

Amar Kendale has already raised $70M for his latest venture. A healthtech startup focusing on a sizable, yet underserved niche, with big potential for impact. His startup, Homeward, has attracted funding from top-tier investors like Breyer Capital, Glen Tullman, Human Capital, and Blackstone Group.

In this episode, we take a discerning look at Startup Genome's Annual Ecosystem Report, seeking to comprehend what the data reveals about Austin's innovation landscape, while also critically examining and challenging it where discrepancies arise. Forrest Wright, Research Assessment Lead at Startup Genome, joins us to decode the metrics and shed light on Austin's present and future trajectory in the innovation sector.Episode HighlightsStartup Genome's insightful report evaluates 290+ global startup ecosystems by scrutinizing six pivotal metrics: performance, funding, market reach, connectedness, talent, and knowledge.Despite a global 35% decline in startup funding in 2022, an unexpected trend emerged - the amount of funding per startup saw a significant surge, with AI cementing its position as a leading sector.Singapore's meteoric rise in the rankings from 18th to 8th is attributed to an influx of venture capital funding, the creation of 4 billion-dollar exits, and the emergence of 18 unicorns, including Coda Payments, which secured an impressive $690M in Series C. Demonstrating resilience and harboring potential for growth, Austin holds steady at 25th in the rankings despite a 30% fall in large-scale exits, countered by its burgeoning count of 12 unicorns.Breyer Capital, Bedrock Capital, and 8VC are among the heavyweights moving to Austin, signaling a strong belief in its ecosystem. This migration starkly contrasts Startup Genome's more retrospective rankings and the forward-looking confidence expressed by these industry leaders.What's next Austin? “The future is really bright. I think it actually bodes really well for Austin is you have these stalwart AI companies already there like SparkCognition, Mythic, and Tethr. I think they've all raised north of a hundred million dollars and some of them much more than that. And so I think this is a lot of built-in institutional knowledge that's going to be a real advantage for Austin compared to a lot of companies that are starting now to kind of jump on the bandwagon. Austin's going to have a real advantage there.”Episode LinksForrest Wright: LinkedInStartup Genome: Website, LinkedIn, TwitterStartup Genome Global Startup Ecosystem Report 2023 Austin Next Links: Website, X/Twitter, YouTube, LinkedIn

Today's guests are using machine learning to turn real world data from past interactions into insights. Dr. Hyde is the co-founder and CEO of Atropos Health which has commercialized the insights exchange for healthcare. Dr. Hyde raised a $14M series in August 2022 from an exceptional group of investors including Breyer Capital and Emerson Capital. Dr. Hyde is joined by an early user of Atropos, Dr. John Halamka, President of the Mayo Clinic Platform. Dr. Halamka has been developing and implementing healthcare information strategy and policy for more than 25 years. He specializes in artificial intelligence, the adoption of electronic health records and the secure sharing of healthcare data for care coordination, population health, and quality improvement. He was elected to the National Academy of Medicine in 2020.For AI and the Future of Work trivia buffs this is one of only three episodes we've recorded with multiple guests. The last one with Tooso founders Ciro Greco and Jacopo Tagliabue was one of our most memorable.Listen and learn...Why ChatGPT shouldn't be used for medical diagnosesHow Atropos uses healthcare data from the Mayo Clinic Platform combined with AI to assist caregiversHow to use AI to automate the research that can otherwise takes weeks or monthsHow the lack of access to data-driven recommendations leads to dangerous patient outcomesWho is responsible when AI makes a bad decision that adversely impacts a patientHow to use NLP to remove PII to make it usable by AI (and certify data hygiene)The challenges of managing patient data at scale in a way that complies with HIPAA regulationsReferences in this episode...ChatGPT's phenomenal adoption rate... by the numbersCiro and Jacopo from Tooso (acquired by Coveo) on AI and the Future of WorkPaddy Padmanabhan on AI and the Future of WorkDipanwita Das, Sorcero CEO, on AI and the Future of WorkThe Mayo Clinic PlatformAtropos Health

Ben Lamm has already started a handful of companies, with just as many exits. He is now onto his biggest adventure year. An effort to rewild the planet, which has already attracted $225M in capital and 50 advisors. The startup, Colossal Biosciences, acquired funding from top-tier investors like Thomas Tull, Breyer Capital, Draper Associates, and At One Ventures.

Gene Hoffman has started and sold several startups. As well as becoming one of the youngest CEOs of a public company in the United States ever. His latest venture, Chia Network, has attracted funding from top-tier investors like True Ventures, Richmond Global Ventures, Breyer Capital, and Naval Ravikant.

SEATTLE—-Karat, the interviewing company, announced the acquisition of Triplebyte's technical assessment product and team. The acquisition adds a unique top-of-funnel, skills-based assessment to Karat's suite of Interviewing Cloud offerings, helping organizations identify and hire the best tech talent faster, more accurately, and fairly. https://hrtechfeed.com/karat-acquires-leading-adaptive-assessment-technology-from-triplebyte/ RiseKit, a US-based startup looking to change the way enterprises source diverse talent from community organizations, recently raised $4.75 million in funding to support DEI initiatives. https://hrtechfeed.com/risekit-raises-4-75m-for-recruiting-diverse-talent/ In a move to further provide its customers with efficient and robust hourly hiring processes, Fountain, the world's leading applicant tracking system (ATS) for high volume hiring, today announces the launch of Fountain AI to its suite of hiring solutions. https://hrtechfeed.com/fountain-launches-a-new-conversational-ai-feature/ HeadRace, a recruiting platform, announced today that it raised $6M in seed funding from Greylock, Susa Ventures, and Breyer Capital with Packy McCormick, Kindergarten Ventures, and Blue Lion Global participating in the round. The company also announced that its technology platform is now available to any recruiter or employer who wants to use it. https://hrtechfeed.com/headrace-lands-6m-to-democratize-the-recruiting-industry/ Barley, a compensation management platform that makes it easy for companies to structure, analyze and manage pay, launched last week with $4 million in seed funding led by Golden Ventures. https://hrtechfeed.com/barley-launches-with-4m-in-seed-funding-to-make-compensation-more-structured-transparent-and-fair/

The dodo bird isn't coming back anytime soon. Nor is the woolly mammoth. But a company working on technologies to bring back extinct species has attracted more investors, while other scientists are skeptical such feats are possible or a good idea. Colossal Biosciences first announced its ambitious plan to revive the woolly mammoth two years ago, and said it wanted to bring back the dodo bird, too. “The dodo is a symbol of man-made extinction,” said Ben Lamm, a serial entrepreneur and co-founder and CEO of Colossal. The company has formed a division to focus on bird-related genetic technologies. The last dodo, a flightless bird about the size of a turkey, was killed in 1681 on the Indian Ocean island of Mauritius. The Dallas company, which launched in 2021, also announced it had raised an additional $150 million in funding. To date, it has raised $225 million from wide-ranging investors that include United States Innovative Technology Fund, Breyer Capital and In-Q-Tel, the CIA's venture capital firm which invests in technology. The prospect of bringing the dodo back isn't expected to directly make money, said Lamm. But the genetic tools and equipment that the company develops to try to do it may have other uses, including for human health care, he said. Other scientists wonder if it's even advisable to try, and question whether “de-extinction” diverts attention and money away from efforts to save species still on Earth. It helps if they can learn from other wild animals of their kind — an advantage that potential dodos and mammoths won't have, said Boris Worm, a biologist at the University of Dalhousie in Halifax, Nova Scotia, who has no connection to Colossal. “Preventing species from going extinct in the first place should be our priority, and in most cases, it's a lot cheaper,” said Worm. This article was provided by The Associated Press.

Michael Dell and Jim Breyer are pioneers in their fields. In this conversation, they will reflect on their past success, goals for the future, and emerging technology opportunities in Austin. Michael is Chairman and CEO of Dell Technologies, the Founder of MSD Capital, and the Co-Founder of the Michael & Susan Dell Foundation. Michael is also the author of two books, Direct from Dell and Play Nice But Win. Jim is the Founder and CEO of Breyer Capital, a venture capital firm based in Austin, TX. Jim has as invested in and/or served on the board of companies like Dell, 21st Century Fox, Etsy, Facebook, Spotify, Marvel Entertainment, Wal-Mart, Blackstone, and MSDAU (Michael's SPAC). Starting in 2015, Jim has developed a deep personal and investment interest in AI and quantum technology.

Our anchors begin today's show with CNBC's Dom Chu analyzing what to expect from tech earnings season. Then, our Julia Boorstin and Evercore ISI Head of Internet Research Mark Mahaney preview Netflix's Q4 results after the bell, and Breyer Capital Founder and CEO Jim Breyer shares his expectations for Meta and TikTok. Next, CNBC's Robert Frank looks at whether Elon Musk could be facing headaches on his tax bill after taking over Twitter, and CNBC's Ylan Mui reports on the U.S. officially hitting its debt limit. Later, Crossmark Global Investments CIO Bob Doll offers his predictions for 2023, and CNBC's Kate Rooney covers crypto lender Genesis preparing to file for bankruptcy.

On the second episode of this season, we chatted with Leo Grady Ph.D. Our conversation focused on his career working at medical technology companies and the many applications of AI in healthcare. Leo is internationally recognized for his work to deliver AI in healthcare for 20 years at the multinational medical company Siemens and pioneering startups HeartFlow and Paige.AI. As CEO of Paige, Leo led the company to become an industry leader, internationally launching groundbreaking products and receiving the first-ever FDA approval for an AI product in pathology. Leo is currently CEO in Residence with Breyer Capital and Founder and CEO of Jona.

In der Rubrik “Investments & Exits” begrüßen wir heute Tina Dreimann, Co-Founder von better ventures. Tina hat die News von Patagonia, der neue Fonds von Junction und die Finanzierungsrunden von NeoCarbon und Prolific Machines analysiert: Der 83-jährige Patagonia-Gründer Yvon Chouinard und dessen Familie haben die etwa drei Milliarden US-Dollar schwere Firma Patagonia komplett einer Treuhandgesellschaft bzw. einer Non-Profit-Organisation geschenkt. Chouinard hat zusammen mit seiner Frau und seinen beiden Kindern sowie einem Team von Anwälten eine Struktur geschaffen, die es Patagonia ermöglicht, weiterhin als gewinnorientiertes Unternehmen zu operieren, dessen Erlöse in den Umweltschutz fließen. „Ab sofort ist die Erde unser einziger Aktionär“, teilte das Unternehmen mit. Mit dem Ziel, eine entscheidende Rolle bei der Energiewende in Europa zu spielen, wurde ein neues, wirkungsorientiertes Unternehmen gegründet: Junction. Der Fonds plant, insgesamt 100 Millionen Euro in Startups für grüne Energietechnologien in ganz Europa zu investieren, und hat gerade einen ersten Betrag von 75 Millionen Euro geschlossen. Zu den Köpfen hinter dem Projekt gehören der Mitbegründer von REstore, Pieter-Jan Mermans, der frühere Inven-Partner Vincent Gregoir, der Gründer des Ökostromanbieters Lampiris, Bruno Vanderschueren, und Dirk Dewals, der zuvor im Vorstand des Private-Equity-Unternehmens GIMV tätig war. NeoCarbon, ein in Berlin ansässiges Tech-Startup, das Kühltürme nachrüstet, um Kohlendioxid aus der Atmosphäre zu entfernen, gab heute bekannt, dass es 1,25 Millionen Euro eingeworben hat. Die Finanzierungsrunde wird von PropTech1 und Speedinvest gemeinsam angeführt, mit Beteiligung von Antler und Angel-Investoren. An der Runde des Direct Air Capture (DAC) Unternehmen beteiligten sich auch mehrere hochkarätige, auf ClimateTech spezialisierte Angel-Investoren wie die Foundeirn von Planetly Anna Alex, Stefano Bernardi und Matthias Ernst. Das frische Kapital wird die Skalierung der Technologie von NeoCarbon vom Laborstatus hin zu einem kommerziellen Pilotprojekt durch die Erweiterung des Ingenieurteams ermöglichen. Prolific Machines, ein in San Francisco, Kalifornien, ansässiges BioTech, hat 42 Millionen US-Dollar in einer Seed- und Series-A-Finanzierung erhalten. Die erste Runde von Prolific wurde Ende 2020 abgeschlossen, als SOSV's IndieBio die Pre-Seed-Runde anführte. Die Seed-Runde wurde von Arvind Gupta von Mayfield geleitet. Die Series A wurde von Breakthrough Energy Ventures geleitet, mit Beteiligung von David Adelman, Mark Cuban, The Kraft Group, David Rubenstein, Michael Rubin, Breyer Capital, The SALT Fund, Purple Orange Ventures, Fred Blackford, Jake Poliskin, Baruch Future Ventures, David Adelman, Mark Cuban, The Kraft Group, Kevin Love, Tobias Harris, Meek Mill, Ciara & Russell Wilson, Emily Ratajkowski, Maverick Carter, Sean Feeney, Michael Schulson, Mark Bucher, und RJ Melman. Das von CEO Dr. Deniz Kent geleitete Unternehmen Prolific Machines ist ein Hersteller von biologischen Produkten, der sich zunächst auf gezüchtetes Fleisch konzentriert, das zellagnostisch ist. Patagonia hat kein Bock das Leute ihre Jacke kaufen: https://eu.patagonia.com/de/de/story-18615.html Infos der Werbepartner: ROQ: Gehe jetzt auf roq.tech/daily und erhalte die komplette Plattform 3 Monate lang for free.

We begin today's show with CNBC's Chief General News Anchor Shepard Smith reporting on concerns over the health of Queen Elizabeth II. Then, Verge Editor-in-Chief Nilay Patel breaking down comments from Apple CEO Tim Cook, Former Disney CEO Bob Iger and more at Vox Media's Code 2022 conference. Next, Breyer Capital Founder and CEO Jim Breyer offers his outlook for opportunities in tech. Later, Production Board Founder and CEO David Friedberg discusses a potential rough winter ahead for founders across the sector, and CNBC's Steve Kovach covers the latest new products unveiled yesterday by Apple.

Over the last 10 days, we have seen unprecedented levels of layoffs from some of the biggest quick commerce providers in the world from Getir to GoPuff to Zapp and Gorillas. Today we dive into the world of quick commerce in emerging markets to uncover what is the same and what is different about the model in emerging markets. Usman Gul is the Founder & CEO @ Airlift, one of the fastest-growing quick commerce providers in the world with core operations in Pakistan. Airlift has raised over $100M in funding from First Round, Josh Buckley, Sam Altman, and 20VC. Ralf Wenzel is the Founder & CEO @ JOKR, a unique provider in the quick commerce market with their dual operations in both the US and LATAM. They are one of the only providers to operate in both emerging and developed economies. To date, JOKR has raised over $288M from Softbank, Balderton, GGV, and Kaszek to name a few. Aadit Palicha is the Founder & CEO @ Zepto, they have taken the Indian quick commerce market by storm since their early days in YC. To date, Aadit has raised over $360M with Zepto from YC, Lachy Groom, Breyer Capital, and Rocket Internet to name a few. In Today's Episode on Quick Commerce in Emerging Markets You Will Learn: 1.) Emerging Markets vs Developed Economies: Where is Quick Commerce Best? What are the single biggest benefits for quick commerce providers in emerging markets? What are the single biggest challenges of operating quick commerce companies in emerging markets as compared to developed economies? From a cost of goods and delivery perspective, what is the single biggest difference comparing operating in emerging markets? 2.) Warehouses, Picking and Delivery: The Economics Broken Down: What % of revenue does Zepto, Airlift and JOKR spend on average for new warehouses in mature markets? How does this change over time? How do they select warehouse locations? What % of revenue is picking costs for Zepto, Airlift and JOKR? What are some needle moving things that could reduce this picking cost? What % of revenue is delivery costs for Zepto, Airlift and JOKR? What levers can make this driver efficiency and delivery cost more efficient? What % of AOV does Airlift and Zepto charge for delivery? How does Zepto leverage power users to subsidise the delivery costs for newly acquired users? Why does JOKR not agree with charging delivery fees? How does charging delivery fees impact usage, frequency and AOV? 3.) Product Selection and Margins: Who Goods Have The Highest Margins? How do Zepto, Airlift and JOKR select the products they sell? How do the margins differ across different product categories? Why is fruit and vegetable the most important category for all three providers? What other metrics are heavily impacted by large spend on fruit and vegetable spend? 4.) AOV and Customer Spend: What is Good? What is the AOV for Airlift, JOKR and Zepto today? How do new markets compare to more mature markets? What are the drivers of the increase? Why does Zepto not believe that AOV is the right metric to be tracking? Why is gross profit per order the right metric to be tracking? 5.) Additional Business Models: Advertising: How much revenue does JOKR, Airlift and Zepto make from advertising revenue today? What can be done to increase this? How have JOKR been able to scale advertising revenue in such a short space of time? What has worked? What has not worked? How important is advertising revenue to the future sustainability of the business model?

Our anchors begin today's show hunting for value amid volatility in tech with Destination Wealth Management CEO and Founder Michael Yoshikami, and our Julia Boorstin previews today's shareholder meetings from Meta and Twitter. Then, Breyer Capital Founder and CEO Jim Breyer shares his investment outlook in an interview from the World Economic Forum in Davos, Switzerland. Next, Intuit CEO Sasan Goodarzi joins after the financial software provider posted an earnings beat with strong guidance, and CNBC's Kate Rooney reports on venture capital firm Andreessen Horowitz raising $4.5 billion to spend on crypto and blockchain start-ups. MoffettNathanson analyst Lisa Ellis also explains why she cut her price target on crypto exchange Coinbase. Later, CNBC's Kristina Partsinevelos glances ahead to chipmaker Nvidia's results after the bell, and CNBC's Frank Holland offers insight on what to expect from cloud computing firm Snowflake's earnings.

Ryan Williams' startup has not only raised substantial equity for his tech startup but has seen it invest in over $1B in assets. The venture, Cadre has attracted funding from top-tier investors like Harold Callais, Breyer Capital, Goldman Sachs Investment Partner, and Class 5 Global.

Connie and Alex go over this week's technology news and then talk to Jim Breyer, the Founder and CEO of Breyer Capital, a venture capital firm based in Menlo Park, CA, and Austin, TX. Breyer is perhaps best known as the lead investor in Facebook's Series A round, but he has also established a reputation for backing winners in areas as diverse as artificial intelligence, quantum mechanics, and blockchain.  Music: 1. "Inspired" by Kevin MacLeod (https://incompetech.filmmusic.io/song/3918-inspired)2. "Blippy Trance" by Kevin MacLeod (https://incompetech.filmmusic.io/song/5759-blippy-trance)3. "Dream Catcher" by Kevin MacLeod (https://incompetech.filmmusic.io/song/4650-dream-catcher)4. "Pamgaea" by Kevin MacLeod (https://incompetech.filmmusic.io/song/4193-pamgaea)5. "EDM Detection Mode" by Kevin MacLeod (https://incompetech.filmmusic.io/song/3687-edm-detection-mode)License: https://filmmusic.io/standard-license

Yubo Ruan is the Founder of Parallel Finance, a new decentralized lending and staking protocol that just recently passed Binance to be the largest third-party program on Polkadot. The company has a current market share of 20.95% and is backed by top-tier investors including Polychain Capital, Pantera Capital, Lightspeed Ventures and Breyer Capital. Yubo learned about crypto in early 2014, and by June of that year he launched his first company while still in high school. Five years later, Yubo sold the company for over $4M, and by that point had started two VC funds focusing on disruptive technologies, and blockchain and crypto. https://parallel.fi/

Remember Kim Kardashian's notorious Kimoji system, where you could access hundreds of Kim themed emojis and gifs? The modern iteration of that is what the startup Genies is offering to thousands of celebrities, and ultimately to you as well. Genies is currently working with A-list celebrities such as Justin Bieber, Shawn Mendes, Migos, Cardi B, etc. to help them create dynamic and photorealistic avatars that they can share on platforms like TikTok and Instagram as a way to engage their fans, tell digitally native stories and perpetuate their brands. For Akash Nigam, the CEO of Genies, avatars represent more than just a PR enabler for celebrities. As someone who struggled with social anxiety and always found it more comfortable to connect with others behind the keyboard, he sees avatars and digital identities as a way to be exactly who you want to be and recreate yourself to match your insides. Especially in a world where there is so much toxicity on the internet, and judgment towards people's physical selves, Akash views pseudonymous avatars as a critical step to building connections with like-minded people irrespective of your physical construct. In today's episode, we'll explore where he thinks the future of avatar technology is headed. Including decentralized ownership and creation, a marketplace on the blockchain, and digital communities as the future iteration of country clubs and the Greek system.ABOUT THE GUESTAkash Nigam is the CEO of Genies, the world's largest avatar technology company. The company has set the foundation for swift, widespread adaptation of avatars in society and culture, allowing individuals to authentically express themselves. The technology features digital wearable goods that can be sold as NFTs, a marketplace built with Dapper Labs, and API integrations for consumer platforms. Investors include Bond, NEA, Breyer Capital, CAA, and Tull Investment Group.He is also the founder of the Genies' investment arm, HUMANS, where they have invested in companies such as OpenSea, Dapperlabs, Clubhouse, etc. He is passionate about NFT identity projects and sees online communities as the future iteration of country clubs and the Greek system. He is also a proud member of the Bored Ape Yacht Club. SHOW NOTES[2:20] Significance of avatars[8:30] Importance of pseudonymity [11:40] Humanoid vs creature system[14:30] Use cases for Genies [19:30] Avatar creation and marketplace[22:20] Moving towards decentralization[27:30] Online communities are the new country clubs[29:50] How to facilitate positivity on Web 3

Our anchors kick off the show with today's market sell-off live from the Code Conference in Los Angeles. Then, Breyer Capital Founder and CEO Jim Breyer joins to give his take on the sell-off, semiconductors, Facebook and much more. Next, we bring in New York Times Contributor and “Sway” podcast host Kara Swisher to break down some of Code's most notable moments, including comments from Microsoft CEO Satya Nadella and Netflix Co-CEO Ted Sarandos. We also have CNBC's Josh Lipton for a closer look at what's moving on the Nasdaq today. Then, we hear from Qualcomm CEO Cristiano Amon, NBA Hall of Famer Earvin “Magic” Johnson and Loop Capital CEO Jim Reynolds as Qualcomm kicks off its third annual Smart Cities Accelerate Event. Plus, CNBC's Dom Chu joins for more on today's dive to the downside.

Brandon Krieg is the co-founder and CEO of Stash which is a New York-based digital investing and banking platform. The company has raised over $300 million from top tier investors including Founders Fund, Union Square Ventures, T. Rowe Price, Greenspring Associates, Coatue Management, Entree Capital, Valar Ventures, Goodwater Capital, Breyer Capital, and Lending Tree to name a few. Prior to this, he co-founded Edge Trade (acquired by Knight Capital Group).

Jim Breyer has his hands in many pots. From helping to choose a new president for Harvard University to running his VC company, Breyer Capital, Breyer has developed a keen eye for talent and investments that pay off. As one of the first investors in Facebook (bought at .05 cents a share), hear his insider's take on that social network, his favorite qualities in an entrepreneur and lots of talk about AI, the tech field he says is growing at a speed heretofore unseen.